We here report a serious adverse event in which a patient was transplanted with stem cells from an incorrect donor due in large part to the inappropriate use of a supposedly unique donor identifier. The purpose of this report is to make the international transplant community aware of this severe adverse event, which has the potential to occur anywhere, and to emphasize the importance of a global unique donor identifier.
Allogeneic haematopoietic stem cell transplantation is a widely used treatment, and potentially curative for a variety of malignant and certain life-threatening non-malignant diseases. 1 When no suitable sibling donor can be found, a search for a suitable HLAmatched unrelated donor is initiated. 2, 3 The search for a potential unrelated donor is performed in international databases, which contain data and HLA type on voluntary stem cell donors and managed by stem cell donor registries. The process of searching and selecting a donor and whom to contact is a complex procedure. 4 The search is initiated on behalf of the requesting transplant center and usually performed through the local registry. The search creates a search report listing all potential donors from different countries and registries, each associated with a unique donor identifier. When a donor of interest is identified on the search report, further information has to be gathered from the donor (e.g., health information) and HLA typing needs to be verified. To that end, information and blood samples are exchanged between institutions. Subsequently, if the donor is found to be a suitable match, donor is recalled for workup, and again, information has to be exchanged between institutions (i.e., updated health information and transport of stem cell products). Usually donors are managed by donor-and collection centers, whereas the registry maintains the donor database and the search, but the organizational relationships between registries and donor centers vary. Registries may act as a donor center or can cooperate with one or several independent donor centers and/or collection centers. Regardless of organization, this procedure involves communication between many institutions: transplant centers, registries (national and international), donor centers and collection centers. Often pre-workup communication happens between registries, whereas communication in the workup and collection process can be directly between transplant center and donor/collection center. One crucial item throughout this communication is the unique donor identifier. The unique donor identifier is used for identification of donor both in communication between institutions and inside institutions, and for correct identification of blood samples and stem cell products. The World Marrow Donor Association (WMDA) standards state that each donor should be given a unique donor identifier. 5 The unique donor identifier is used to ensure confidentiality and anonymity of the donors, so that the identity of the donors and their rights are protected. The number must be unique to ensure traceability between donors and their associated data, and biological material and their participation in the donation process in long term.
At present, no common international guideline for constructing a unique donor identifier exists, and a search report for a given patient can consist of donors listed from different registries with unique donor identifiers constructed differently. Often, in the database the unique donor identifier is constructed by adding a prefix to a sequential number, but may also consist of numbers alone. In addition, for practical and technical reasons any potential donor and his or her blood samples or stem cell products can have multiple unique donor identifiers (e.g., social security number, blood bank unique donor identifier and registry unique donor identifier), and other multiple donor identifiers (e.g., birth date and sex). Which unique donor identifier is used often depends on which institutions are communicating, for example, a donor can be assigned one unique donor identifier for internal use and another for international use in the search database. The unique donor identifier is sometimes used alone; sometimes together with one or more of the donor's other unique donor identifiers in documents, on labels or others. This use of multiple unique donor identifiers for the same donor is prone to error as the following case story will reveal.
A male patient, born in 1960, was referred for allogeneic transplantation with a T-cell lymphoma in second CR. A 9/10 allele HLA-matched (HLA-A, -B, -C, -DRB1 and -DQB1) unrelated donor (donor 1) was identified in June 2012. Allogeneic stem cell transplantation was scheduled for September 2012, including arrangements with the donor center (donor center 1). The transplant was canceled because the patient's disease relapsed after which the patient received further treatment and achieved a third CR. A non-myeloablative conditioning regimen transplant was performed in May 2013 with a stem cell graft thought to be from donor 1. One month post transplant, it was recognized that the patient had been transplanted using the wrong donor, due to a query from donor center 1 asking whether their donor (donor 1) was still needed. It was then realized that the patient had been transplanted from donor 2, who turned out to be a complete HLA mismatch (0/10). National and international cooperative transplant centers were consulted, and although the patient was in CR, without evidence of GvHD and fully engrafted with 100% donor chimerism, it was evaluated that this transplantation would eventually turn out to be fatal and therefore a second transplant using non-myeloablative conditioning was performed 2 weeks later with the correct donor 1. Eleven months after the retransplantation the patient died from an intracerebral hemorrhage. At that time he was in CR.
When the error was discovered, the sequence of events was reconstructed:
• The unrelated donor search was performed by the local registry (Registry A), and a potential international donor (donor 1) was identified by communication with a foreign registry (Registry B).
In the international search database, the donor was identified by a letter prefix followed by an eight digit number (e.g., A12345678).
• Registry A requested blood samples from Registry B for verification HLA typing of donor 1 using the unique donor identifier from the international search database. Donor 1 was a female and identified as a 9/10 allele match, with an allele mismatch at HLA-DRB1. The transplant center was informed of this potential donor by Registry A. In the report from the HLA typing laboratory the unique donor identifier was recorded incompletely (the prefix was omitted: i.e., 12345678), due to a field constraint of the IT system. • The workup request was sent by the transplant center directly to a wrong donor center (donor center 2) without involving Registry A and B in the two countries. In the workup request the unique donor identifier was copied from the HLA typing report and therefore without the prefix. The workup request was written on a WMDA form and was otherwise correct-including the HLA types of the patient and the requested donor 1.
• Donor center 2 had a donor (donor 2) with a similar number, but different prefix (B12345678). The donor center had no documented procedure, which required the unique donor identifier to be complete. Other donor identifiers were not checked (birth date, sex and HLA typing). Donor 2 was a male and a 0/10 match.
• At the transplant center only the number-and not the prefixwas considered important. The transplant protocol was signed by a physician based on the HLA report and the final donor clearance. The HLA report indicates the HLA type of donor 1 and therefore a match to the patient, but used the donor ID without prefix (12345678), and the final donor clearance used the donor ID with a different prefix (B12345678). Other donor identifiers, such as birth date and sex were not checked. The stem cell product was labeled with the correct donor ID from donor 2 (B12345678), but again, at identification control before infusion, only the number was considered important.
The event was reported to the national authorities as a severe adverse event and to the World Marrow Donor Association Serious (Product) Events and Adverse Reactions (WMDA S(P)EAR) committee. 6 This committee reviewed the serious adverse events (SAE) and due to the possibility that such event could occur again, an alert was sent from the WMDA to all members and professional societies to raise awareness.
A root cause analysis has been performed by all parties ( Table 1) . As is common in such cases, multiple system error-prone practices were found. On the basis of this, corrective actions were initiated ( Table 2 ). On basis of this SAE, the WMDA S(P)EAR committee made some recommendations as mentioned in Table 2 and have made a proposal to the WMDA Standards Committee to have them included in the WMDA standards.
In conclusion, this is an example of a severe adverse event, which is important to communicate to all parties involved in transplantation, so that precautions can be taken in order to avoid another similar SAE. This report demonstrates the need for a Table 1 . Root cause analysis
Error prone practice Comment
At critical time points the prefix was omitted from the unique donor identifier, and the unique donor identifier was not required to be complete at the donor center or at the transplant center A unique donor identifier is essential in every communication, and therefore it is important that unique donor identifier is written correctly. In this actual case the first error to occur was omitting the prefix in the report from the HLA typing lab., and that another donor center had a donor with a duplicate number (but different prefix). The prefix was not considered important as a part of the unique donor identifier No WMDA guideline exists how to construct the donor identifier, only that is must be unique. Unique donor identifiers are constructed differently from registry to registry and some donors can have more than one unique donor identifier. This is prone to induce inappropriate use of donor identifiers. The Danish Bone Marrow Donor Registry did a small study on inappropriate use of donor identifiers in 2013 and found that in 28% of all requests for HLA verification typing on international donors, donor was identified with more than one unique donor identifier and in 3 out of 15 workup requests the unique donor identifier was written without the prefix "DK" and only the numeric number was shown, which is not unique. A single system for unique donor identifier would secure an inappropriate use of unique donor identifiers. The workup request and communication was between transplant center and donor center and did not involve the registries in the two countries Transplant centers are allowed to contact donor centers directly, but WMDA guidelines advise that workup is to be performed through the national hub. 7 The transplant center contacted the wrong donor center directly. They had used this donor center before. Therefore, contact details were known and the donor ID without prefix were resembling donor IDs from that donor program. If the workup request had been handled by both registries, it would have been sent to the correct donor center. All pre-workup requests had been between Registry A and Registry B. The registry is aware of all requests for a specific patient regardless of the donor center to which the donor belongs. By using the patient as an entry for all requests, you can only proceed by using the correct donors that have already been linked to the patient during previous requests, for example, request for verification of HLA typing. Systems for checking multiple identifiers were not in place. The donor center did not recognize that the HLA typing on the workup request was not identical to the HLA type of their donor and neither the donor center nor the transplant center recognized the different gender of the donor A process to check multiple donor identifiers must be in place, and it should be used as early as possible in the workup process, for example, when the donor center receives a workup request and when transplant center receives a workup schedule. If this is secured, only the unique donor identifier needs to be checked at donation or infusion. If the donor has several unique donor identifiers, it must be clear which unique donor identifier is used on all communication, on blood samples and products, and therefore can be used for identification control. In this case no ABO type was performed on a blood sample from donor, but this would not have prevented this error, as both donors were blood type A RhD pos.
Abbreviation: WMDA = The World Marrow Donor Association.
Letter to the Editor global unique donor identifier and that this severe adverse event could recur elsewhere. Indeed, since this report, the WMDA S(P) EAR committee is aware of a similar case with a mix-up of donors during the workup process.
